Price target
9.760.000.00%
The 5 analysts offering 1 year price forecasts for NYKD have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to NYKD in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NYKD EPS for the last quarter is −0.32 NOK despite the estimation of −0.47 NOK. In the next quarter EPS is expected to reach −0.54 NOK. Track more of NYKODE THERAPEUTICS ASA financials and stay on top of what is up with the company.
In the next quarter NYKODE THERAPEUTICS ASA revenue is expected to reach 18.85 M NOK. Check out NYKODE THERAPEUTICS ASA revenue and earnings and make informed decisions.
According to analysts, NYKD price target is 9.76 NOK with a max estimate of 25.05 NOK and a min estimate of 2.50 NOK. Check if this forecast comes true in a year, meanwhile watch NYKODE THERAPEUTICS ASA stock price chart and keep track of the current situation with NYKD news and stock market news.
We've gathered opinions of 5 analysts rating NYKD stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.